Seroprevalence of COVID 19 in childre

Not Applicable

Completed

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/09/028040
• Lead Sponsor: CTMRF KKCTH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-12-31
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 468

Inclusion Criteria

All children between 1 month and 18 years

Exclusion Criteria

Caretakers and children unwilling to participate

Children in whom blood draw is not justified eg anaemia

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Proportion of children with seropositivity for SARS-CoV-2 infection <br/ ><br>2.Proportion of asymptomatic children with positive COVID 19 <br/ ><br>3.Proportion of children who show symptoms or signs of COVID-19 infection <br/ ><br>4. Proportion of children with PIMS-TSTimepoint: baseline

Secondary Outcome Measures

Name	Time	Method
To corelate the serology titres with the severity of diseaseTimepoint: baseline